THE DEAL, AT A GLANCE
From the announcementXaira Therapeutics
01Who is involvedBacked by ARCH Venture Partners, Foresite CapitalFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedXaira Therapeutics raised $1B Series AFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersXaira Therapeutics' $1000M Series A represents a top-decile capital-flow signal in Healthcare & Life Sciences, with the round sitting at the 98th percentile of tracked…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Xaira Therapeutics · Financing Record
Explore source-linked visual explanations for Xaira Therapeutics. Unsupported claims are withheld while source review continues.
Record 78 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →